MENU
ACLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arcellx (ACLX) Earnings Date & Reports

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more

A.I. Advisor
published Earnings

ACLX is expected to report earnings to fall 10.98% to -88 cents per share on February 26

Arcellx ACLX Stock Earnings Reports
Q4'25
Est.
$-0.88
Q3'25
Missed
by $0.03
Q2'25
Beat
by $0.08
Q1'25
Missed
by $0.37
Q4'24
Missed
by $0.31
The last earnings report on November 05 showed earnings per share of -99 cents, missing the estimate of -95 cents. With 341.38K shares outstanding, the current market capitalization sits at 5.21B.
View a ticker or compare two or three
ACLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACLX showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
130
Web
https://www.arcellx.com